Dominique Plantaz
Distinguished in Lysosomal Acid Lipase Deficiency

Dominique Plantaz

Grenoble, FR 
Clinical Trials:Currently Recruiting for 3 Trials
Distinguished in Lysosomal Acid Lipase Deficiency
Grenoble, FR 
OverviewLocationsClinical Research

Overview

Dominique Plantaz practices in Grenoble, France. Plantaz is rated as a Distinguished expert by MediFind in the treatment of Lysosomal Acid Lipase Deficiency. Their top areas of expertise are Lysosomal Acid Lipase Deficiency, Cholesteryl Ester Storage Disease, Wolman Disease, Bone Marrow Transplant, and Splenectomy.

Their clinical research consists of co-authoring 104 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Lysosomal Acid Lipase Deficiency.

Locations

Grenoble, France
Other Locations
CHU Bordeaux
Bordeaux, France
Toulouse, France
Nantes, France
Av. Des Maquis Du Grésivaudan, La Tronche, 38700, France
Amiens, France
Montpellier, 34090, France
Poitiers, France
Paris, France
Saint-etienne-de-valoux, 75012, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Ocular Conservative Treatment for Retinoblastoma: Efficacy of the New Management Strategies and Visual Outcome - RETINO 2018
Enrollment Status: Recruiting
Publish Date: November 28, 2025
Intervention Type: Drug, Device
Study Drugs: Melphalan or Melphalan + Topotecan, Etoposide, Carboplatin and Vincristine, Carboplatin, Intravitreal Melphalan Chemotherapy Injections
Study Phase: Phase 2/Phase 3
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated
Enrollment Status: Recruiting
Publish Date: September 15, 2025
Intervention Type: Procedure, Drug, Radiation, Other
Study Drugs: Etoposide, Vincristine, Carboplatin, Cyclophosphamide, Thiotepa
Study Phase: Phase 2
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
CombinaiR3 - First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years
Enrollment Status: Completed
Publish Date: November 21, 2025
Intervention Type: Radiation, Drug, Procedure
Study Drugs: VDC-IE x2, VDC-IE, TEMIRI, Consolidation BuMel, Maintenance
Study Phase: Phase 2
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Pan-genome Analysis of Neuroblastoma by Comparative Genomic Hybridization and Correlation With Pathology for the Diagnostic and the Prognostic Classification
Enrollment Status: Completed
Publish Date: December 01, 2023
Intervention Type: Procedure
Study Phase: Not Applicable
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Enrollment Status: Completed
Publish Date: November 18, 2020
Intervention Type: Drug
Study Phase: Phase 2
Review of the Paediatric Pleuropulmonary Blastoma French Series
Review of the Paediatric Pleuropulmonary Blastoma French Series
Enrollment Status: Completed
Publish Date: August 12, 2020
Intervention Type: Other
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Immunomonitoring of Children With Neuroblastoma for the Development of Antitumor Immunotherapy Strategies
Enrollment Status: Unknown
Publish Date: August 23, 2018
Intervention Type: Other
Study Phase: Not Applicable
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Evaluation of the Clinical Utility and Cost Effectiveness Ratio of Generalized Neonatal Screening for Severe Combined Immunodeficiencies (SCID) by Quantification of TRECs on Guthrie Cards
Enrollment Status: Completed
Publish Date: July 24, 2018
Intervention Type: Biological
Study Phase: Not Applicable
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Phase 2 Study of a Reduced-toxicity Myeloablative Conditionning Regimen Using Fludarabine and Full Doses of iv Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens
Enrollment Status: Completed
Publish Date: April 05, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

104 Total Publications

Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.
Interest of a sequential multimodal approach for the treatment of newly diagnosed patients with multimetastatic Ewing sarcoma: results of the French prospective CombinaiR3 phase II trial.
Journal: British journal of cancer
Published: June 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Plantaz's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile